Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Pulmonary embolism Stories

2013-08-07 10:13:29

The D-dimer test is often used to rule out the presence of venous thromboembolism; however, the test has been considered unreliable in postoperative patients because D-dimer levels may rise after surgery. Researchers from the Department of Neurosurgery at the University of Halle in Germany hypothesized that this rise might be systematic and predictable, in which case a feasible postoperative threshold of D-dimer indicating venous thromboembolism could be determined. The results of this study...

2013-08-06 16:27:58

If approved by the FDA, riociguat will be the first treatment for inoperable CTEPH or persistent/recurrent CTEPH after surgery and a new treatment for PAH WHIPPANY, N.J., Aug. 6, 2013 /PRNewswire/ -- Bayer HealthCare today announced that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee recommended approval for investigational riociguat, proposed trade name Adempas(TM), in two forms of pulmonary hypertension. The Committee voted 11 to 0...

2013-08-02 23:19:29

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Denver, CO (PRWEB) August 02, 2013 The birth control safety center at DrugRisk.com is announcing updated news for women using the contraceptive NuvaRing. A federal judge recently denied attempts by the manufacturer to dismiss a lawsuit alleging NuvaRing caused blood clots, allowing the first trial to start in October*....

2013-07-31 23:25:26

With the latest published case out of New York State of a student-athlete developing deep vein thrombosis (DVT), a dangerous condition in which a blood clot forms in one or more veins deep in the body, the New York State Athletic Trainers’ Association (NYSATA), emphasizes the magnitude of having a medical professional, such as a certified athletic trainer (AT), on-hand for athletic events who is well-educated and skilled in recognizing these potentially fatal vascular conditions. St....

2013-07-30 23:29:31

The DrugRisk Center is the web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com. Chicago, IL (PRWEB) July 30, 2013 The birth control safety center at DrugRisk.com has added new information for women who’ve taken the contraceptives Yaz or Yasmin. A new warning out of Canada comes as updated court records show the amount of patients filing a Yaz lawsuit alleging blood clot injuries has increased in recent...

2013-07-30 23:29:14

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today. Kansas City, MO (PRWEB) July 30, 2013 The birth control safety center at DrugNews.net is announcing updated news for women using the contraceptive NuvaRing. A federal judge recently denied attempts by the manufacturer to dismiss a lawsuit alleging NuvaRing caused blood clots, which will allows trials to begin in October*. Health...

2013-07-30 08:33:13

- MYDICAR When Inhaled May Restore Function of SERCA2a Enzyme in the Lungs to Reverse Deadly PAH Condition - SAN DIEGO, July 30, 2013 /PRNewswire/ -- Celladon Corporation, a clinical-stage biotechnology company committed to applying its first-mover, leadership position in the field of SERCA enzymes to transform the lives of patients with important, life-threatening diseases, announced today that an international team of researchers led by investigators at the Cardiovascular Research Center...

2013-07-29 23:26:32

A NuvaRing lawsuit recently filed by Alonso Krangle alleges that the plaintiff’s use of NuvaRing caused her to develop a serious lung condition known as pulmonary embolism and that Organon and others failed to warn the public about the risk of such serious side effects associated with NuvaRing use. New York, NY (PRWEB) July 28, 2013 Alonso Krangle’s attorneys have recently filed a NuvaRing lawsuit against Organon, Merck and others on behalf of a woman from Louisiana. This case (Case...

2013-07-24 23:29:25

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) July 24, 2013 The birth control safety advocates at DrugRisk.com are announcing updated news for women using the contraceptive NuvaRing. A federal judge recently denied attempts by the manufacturer to dismiss a lawsuit alleging NuvaRing caused blood clots, allowing trials to proceed in October*. Health...

2013-07-24 23:00:22

A NuvaRing lawsuit recently filed by Alonso Krangle alleges that the plaintiff’s use of NuvaRing caused her to develop a severe blood clot condition known as deep vein thrombosis and that Organon failed to warn women about the risk of such serious side effects associated with NuvaRing use. New York, NY (PRWEB) July 25, 2013 Alonso Krangle’s attorneys have recently filed a NuvaRing blood clot lawsuit against Organon, Merck and other companies on behalf of a woman from California. This...